Exploring the use of synthetic placebo populations in ALS randomized clinical trials (2022)

First Author: Bowles H

Attributed to: A Programme for ALS Care in Europe (ALS-CarE) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.12.09.22283281

Publication URI: http://dx.doi.org/10.1101/2022.12.09.22283281

Type: Preprint